
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Intrinsic Value
The intrinsic value of one
JAZZ
stock under the Base Case scenario is
311.32
USD.
Compared to the current market price of 100.34 USD,
Jazz Pharmaceuticals PLC
is
Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Jazz Pharmaceuticals PLC
Fundamental Analysis


Revenue & Expenses Breakdown
Jazz Pharmaceuticals PLC
Balance Sheet Decomposition
Jazz Pharmaceuticals PLC
Current Assets | 4.6B |
Cash & Short-Term Investments | 3B |
Receivables | 716.8m |
Other Current Assets | 919.4m |
Non-Current Assets | 7.4B |
PP&E | 227m |
Intangibles | 6.5B |
Other Non-Current Assets | 684.2m |
Free Cash Flow Analysis
Jazz Pharmaceuticals PLC
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Jazz Pharmaceuticals PLC
Revenue
|
4.1B
USD
|
Cost of Revenue
|
-445.7m
USD
|
Gross Profit
|
3.6B
USD
|
Operating Expenses
|
-2.9B
USD
|
Operating Income
|
726.6m
USD
|
Other Expenses
|
-166.5m
USD
|
Net Income
|
560.1m
USD
|
JAZZ Profitability Score
Profitability Due Diligence
Jazz Pharmaceuticals PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Jazz Pharmaceuticals PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
JAZZ Solvency Score
Solvency Due Diligence
Jazz Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Score
Jazz Pharmaceuticals PLC's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for
JAZZ
is 193.94 USD
with a low forecast of 151.5 USD and a high forecast of 241.5 USD.
Dividends
Current shareholder yield for JAZZ is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
JAZZ
stock under the Base Case scenario is
311.32
USD.
Compared to the current market price of 100.34 USD,
Jazz Pharmaceuticals PLC
is
Undervalued by 68%.